US 10202339
Therapeutic compounds and compositions
granted A61KA61K31/17A61K31/18
Quick answer
US patent 10202339 (Therapeutic compounds and compositions) held by Agios Pharmaceuticals, Inc. expires Mon Feb 07 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Agios Pharmaceuticals, Inc.
- Grant date
- Tue Feb 12 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Feb 07 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 11
- CPC classes
- A61K, A61K31/17, A61K31/18, A61K31/351, A61K31/381